Researchers have identified antibodies that could prevent and treat measles, paving the way for the first treatment against the disease.

A team of researchers has discovered human antibodies that can neutralize the measles virus, which could revolutionize the prevention and treatment of this contagious disease.

The study, led by Erica Ollmann Saphire from the La Jolla Institute for Immunology, was published in the journal Cell Host & Microbe. The antibodies bind to key proteins of the virus, preventing it from entering host cells. The researchers isolated these antibodies from the blood of a vaccinated woman, demonstrating that their administration significantly reduces viral load in animal models. The antibodies could be particularly useful for immunocompromised individuals or those who are not fully vaccinated.

Further research is needed to develop an effective treatment based on these antibodies.